Neumayer Matthew Paul

Avg. Two Year Performance

No purchase track record
24% Avg. Sale Return
11% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return13%21%18%17%24%
Sale Success Rate2 of 22 of 22 of 21 of 22 of 2
Drugs » Biotechnology

Principal Accounting Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--